Short Interest in XOMA Co. (NASDAQ:XOMAP) Decreases By 50.4%

XOMA Co. (NASDAQ:XOMAP) was the recipient of a large decrease in short interest during the month of June. As of June 30th, there was short interest totaling 276 shares, a decrease of 50.4% from the June 15th total of 556 shares. Based on an average trading volume of 3,957 shares, the short-interest ratio is currently 0.1 days.

XOMA Stock Performance

NASDAQ:XOMAP traded up $0.01 during mid-day trading on Wednesday, hitting $24.99. 362 shares of the company’s stock traded hands, compared to its average volume of 2,224. The firm’s 50 day simple moving average is $25.34 and its 200 day simple moving average is $25.89. XOMA has a 1 year low of $24.93 and a 1 year high of $30.00.

XOMA Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, July 14th. Stockholders of record on Thursday, July 2nd were given a $0.5391 dividend. The ex-dividend date was Thursday, July 2nd. This represents a $2.16 annualized dividend and a dividend yield of 8.6%.

About XOMA

XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.

Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.